Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Rejuran S
- Development stage
- Unknown
- Lead developer
- PharmaResearch
- Administration
- Intradermal
01
Overview
Rejuran S is a specialized, high-viscosity injectable skin booster and aesthetic medical device developed by PharmaResearch. It is formulated with highly purified polynucleotides (PN) derived from salmon DNA, which are designed to promote tissue regeneration and dermal remodeling. The 'S' in its name stands for 'scar,' reflecting its primary indication for the treatment of depressed acne scars, surgical scars, stretch marks, and burn scars. Mechanistically, the polynucleotides in Rejuran S act as agonists of the adenosine A2A receptor, stimulating dermal fibroblasts to synthesize collagen and elastin, while also providing nucleotides for the cellular salvage pathway to facilitate DNA repair. Due to its high viscosity and gel-like structure, Rejuran S also functions as a physical scaffold to temporarily fill and smooth sunken scars. It is CE-certified and widely used in aesthetic medicine across Asia and Europe.
- Brand names
- Rejuran S
- Other names
- Rejuran S ScarRejuran S Scar PDRN
02
Targets
ADORA2A (Adenosine A₂A Receptor)VEGFA (Vascular endothelial growth factor A)ELN (Elastin)HAS1 (Hyaluronan synthase 2)
Beyond the preview
Go deeper on Rejuran S.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Explore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Trace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Explore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Compare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Connect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Rejuran S.